Latest stories on OKYO
OKYO Pharma Enrolls First Patients in Phase 3 NEPTUNE Trial of Urcosimod for Neuropathic Corneal Pain
TipRanks63 · neutralproduct/pr
Okyo Pharma announces first patients enrolled in NEPTUNE trial
The Fly56 · neutralproduct/pr
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
GlobeNewswire63 · neutralproduct/pr
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
Business Insider63 · neutralproduct/pr
OKYO Pharma to Highlight Neuropathic Corneal Pain Program at Key Ophthalmic Conferences
TipRanks63 · neutralproduct/pr
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
Business Insider63 · neutralproduct/pr
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
GlobeNewswire63 · neutralproduct/pr
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
GlobeNewswire63 · neutralproduct/pr
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
StockTitan56 · neutralproduct/pr
OKYO Pharma to Highlight Urcosimod Progress at Cantor Global Healthcare Conference
TipRanks56 · neutralproduct/pr
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
GlobeNewswire56 · neutralgeneral
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
StockTitan56 · neutralgeneral
Okyo Pharma management to meet virtually with Piper Sandler
The Fly55 · neutralgeneral
OKYO Pharma CSO Increases Stake Ahead of Planned Phase 3 Trial
TipRanks63 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
Business Insider59 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
StockTitan59 · neutralgeneral
OKYO Pharma to Present Late-Stage Ophthalmic Pipeline at BTIG Biotechnology Conference 2026
TipRanks56 · neutralproduct/pr
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
StockTitan56 · neutralgeneral
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
Business Insider56 · neutralgeneral
OKYO Pharma Director Ups Stake Ahead of Planned Phase 3 Neuropathic Corneal Pain Trial
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director
Business Insider55 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Director
StockTitan54 · neutralgeneral
OKYO Pharma CEO Boosts Stake With Nasdaq Share Purchase
TipRanks58 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chief Executive Officer
StockTitan56 · neutralgeneral
OKYO Pharma Announces Purchase of Shares by Chairman
Business Insider59 · neutralgeneral